Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
132.50    2.50 (1.92%)
Bid:
132.50
Ask:
133.00
Spread: 0.50 (0.377%)
Market Cap: £335.08m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Board Appointment

29 Apr 2021 07:00

RNS Number : 9923W
Marshalls PLC
29 April 2021
 

29 April 2021

 

Marshalls plc

(the "Company" or "Marshalls")

 

Board Appointment

 

Justin Lockwood appointed as CFO

 

Marshalls plc, the specialist landscape products group, is pleased to announce the appointment of Justin Lockwood to the Board as Chief Financial Officer.

 

Justin is currently the Chief Financial Officer of International Personal Finance plc. He joined them in 2010 and held a number of senior finance roles prior to his appointment as CFO in 2017. Justin brings extensive experience of all aspects of financial management in large publicly listed companies.

 

Prior to International Personal Finance plc, Justin worked for Associated British Ports for four years in a senior finance role. His first role in industry was with Marshalls, between 2002 and 2006, where he worked in a variety of business unit and head office roles, including as finance director of Marshalls Clay Products before its disposal to Hanson plc. Justin is a chartered accountant, having qualified with PwC where he spent the first 10 years of his career.

 

Justin succeeds Jack Clarke who stepped down from the Board, and as Group Finance Director, on 31 March 2021. His appointment will take effect at a date to be agreed once his departure date from International Personal Finance plc has been finalised.

 

Martyn Coffey, CEO of Marshalls commented:

 

"We're delighted that Justin is joining the business. His rich, cross-sector experience, which includes time with Marshalls earlier in his career, will be an asset to the Board and help us capitalise on future growth opportunities and deliver our strategic objectives. In Justin, we're confident we've found an outstanding successor to Jack Clarke, who made a significant contribution to the sustained growth of Marshalls during his time with us."

 

Justin Lockwood commented:

 

"Marshalls is an exceptional business with strong heritage and a clear strategic vision. I'm delighted to be joining and look forward to working with Martyn, the Board and all of Marshalls' very dedicated colleagues"

 

There are no disclosures required pursuant to Listing Rule 9.6.13.

 

- Ends -

 

The information communicated in this announcement is inside information.

 

Enquiries:

 

Martyn Coffey, Chief Executive

Marshalls plc

+44 (0)1422 314777

Shiv Sibal, Company Secretary

Marshalls plc

+44 (0)1422 314767

Andrew Jaques

MHP Communications

+44 (0)20 3128 8540

Charlie Barker

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWVARAWUSUUR
Date   Source Headline
6th Jul 202111:18 amRNSDirector/PDMR Shareholding
10th Jun 202111:10 amRNSDirector/PDMR Shareholding
4th Jun 202110:37 amRNSDirector/PDMR Shareholding
2nd Jun 20214:09 pmRNSDirectorate Change
12th May 20211:42 pmRNSResult of AGM
12th May 20217:00 amRNSTrading Statement
5th May 20212:25 pmRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSBoard Appointment
16th Apr 20214:57 pmRNSHolding(s) in Company
16th Apr 20211:15 pmRNSDirector Declaration
15th Apr 20214:45 pmRNSHolding(s) in Company
15th Apr 20212:07 pmRNSDirector/PDMR Shareholding
7th Apr 202112:04 pmRNSDirector/PDMR Shareholding
7th Apr 202112:02 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSDirectorate Changes and Annual Financial Report
29th Mar 20214:05 pmRNSHolding(s) in Company
18th Mar 20215:07 pmRNSDirector/PDMR Shareholding
18th Mar 20215:01 pmRNSDirector/PDMR Shareholding
18th Mar 20215:00 pmRNSDirector/PDMR Shareholding
17th Mar 20212:27 pmRNSDirector/PDMR Shareholding
17th Mar 20212:19 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSFinal Results
8th Mar 20215:08 pmRNSHolding(s) in Company
8th Mar 202111:41 amRNSHolding(s) in Company
4th Mar 20213:07 pmRNSDirector/PDMR Shareholding
4th Mar 20213:03 pmRNSDirector/PDMR Shareholding
10th Feb 20213:08 pmRNSHolding(s) in Company
8th Feb 20212:04 pmRNSDirector/PDMR Shareholding
8th Feb 20212:01 pmRNSDirector/PDMR Shareholding
13th Jan 202111:45 amRNSHolding(s) in Company
13th Jan 20217:00 amRNSTrading Statement
4th Jan 20212:48 pmRNSDirector/PDMR Shareholding
4th Jan 20212:47 pmRNSDirector/PDMR Shareholding
4th Dec 202010:35 amRNSDirector/PDMR Shareholding
4th Dec 202010:34 amRNSDirector/PDMR Shareholding
18th Nov 20205:17 pmRNSHolding(s) in Company
16th Nov 20202:37 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSTrading Statement
4th Nov 202010:08 amRNSDirector/PDMR Shareholding
4th Nov 202010:07 amRNSDirector/PDMR Shareholding
2nd Nov 20205:00 pmRNSHolding(s) in Company
28th Oct 202012:44 pmRNSHolding(s) in Company
27th Oct 202012:07 pmRNSHolding(s) in Company
26th Oct 202012:50 pmRNSHolding(s) in Company
22nd Oct 20204:44 pmRNSHolding(s) in Company
21st Oct 20204:30 pmRNSDirector/PDMR Shareholding
14th Oct 202011:26 amRNSHolding(s) in Company
12th Oct 20202:27 pmRNSHolding(s) in Company
6th Oct 20204:16 pmRNSDirector/PDMR Shareholding
6th Oct 20204:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.